Publications by authors named "Dmitry Pankov"

Claim this Profile
D
Development of Resistance to Type II JAK2 Inhibitors in MPN Depends on AXL Kinase and Is Targetable.
Tamara Codilupi, Jakub Szybinski, Stefanie Arunasalam, Sarah Jungius, Andrew C Dunbar, Dmitry Pankov

Clin Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PSA-Targeted Alpha-, Beta-, and Positron-Emitting Immunotheranostics in Murine Prostate Cancer Models and Nonhuman Primates.
Darren R Veach, Claire M Storey, Katharina Lückerath, Katharina Braun, Christian von Bodman, Dmitry Pankov

Clin Cancer Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic reprogramming sensitizes immunologically silent EBV+ lymphomas to virus-directed immunotherapy.
Tanner Dalton, Ekaterina Doubrovina, Dmitry Pankov, Raymond Reynolds, Hanna Scholze

Blood· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCR-mimic bispecific antibodies targeting LMP2A show potent activity against EBV malignancies.
Mahiuddin Ahmed, Andres Lopez-Albaitero, Dmitry Pankov, Brian H Santich, Hong Liu

JCI Insight· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
immuno-targeting of an extracellular epitope of membrane bound preferentially expressed antigen in melanoma (PRAME).
Dmitry Pankov, Ludvig Sjöström, Teja Kalidindi, Sang-Gyu Lee, Kjell Sjöström

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2.
Sayed Shahabuddin Hoseini, Konstantin Dobrenkov, Dmitry Pankov, Xiaoliang L Xu, Nai-Kong V Cheung

Oncoimmunology· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opportunities and challenges for TCR mimic antibodies in cancer therapy.
Aaron Y Chang, Ron S Gejman, Elliott J Brea, Claire Y Oh, Melissa D Mathias, Dmitry Pankov

Expert Opin Biol Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of leukemia resistance to antibody dependent cellular cytotoxicity.
Leonid Dubrovsky, Elliott Joseph Brea, Dmitry Pankov, Emily Casey, Tao Dao

Oncoimmunology· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic bispecific T-cell engager antibody targeting the intracellular oncoprotein WT1.
Tao Dao, Dmitry Pankov, Andrew Scott, Tatyana Korontsvit, Victoriya Zakhaleva

Nat Biotechnol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms.
Sara C Meyer, Matthew D Keller, Sophia Chiu, Priya Koppikar, Olga A Guryanova, Dmitry Pankov

Cancer Cell· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cell receptor mimic antibodies for cancer therapy.
Leonid Dubrovsky, Tao Dao, Ron S Gejman, Elliott J Brea, Aaron Y Chang, Dmitry Pankov

Oncoimmunology· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic efficacy of an Fc-enhanced TCR-like antibody to the intracellular WT1 oncoprotein.
Nicholas Veomett, Tao Dao, Hong Liu, Jingyi Xiang, Dmitry Pankov

Clin Cancer Res· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activity.
Yusuke Shono, Andrea Z Tuckett, Samedy Ouk, Hsiou-Chi Liou, Grégoire Altan-Bonnet, Dmitry Pankov

Cancer Discov· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemias.
Leonid Dubrovsky, Dmitry Pankov, Elliott Joseph Brea, Tao Dao, Andrew Scott

Blood· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the intracellular WT1 oncogene product with a therapeutic human antibody.
Tao Dao, Su Yan, Nicholas Veomett, Dmitry Pankov, Liang Zhou

Sci Transl Med· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping of novel peptides of WT-1 and presenting HLA alleles that induce epitope-specific HLA-restricted T cells with cytotoxic activity against WT-1(+) leukemias.
Ekaterina Doubrovina, Taissia Carpenter, Dmitry Pankov, Annamalai Selvakumar, Aisha Hasan

Blood· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis